Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal vs Intravenous Ketamine for Pediatric Procedural Sedation
NCT02402868Phase 3Completed
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine in bone fracture (Fx) (2 arms). Primary endpoint: University of Michigan Sedation Score at 60 months. Started Jan 2016; status: completed.
02
Drugs
ketamine
03
Conditions
bone fracture (Fx)
Beyond the preview
Go deeper on NCT02402868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02402868.